Tactile Systems Technolog... (TCMD)
undefined
undefined%
At close: undefined
17.91
-0.19%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States.

The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.

The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Tactile Systems Technology Inc.
Tactile Systems Technology Inc. logo
Country United States
IPO Date Jul 28, 2016
Industry Medical - Devices
Sector Healthcare
Employees 992
CEO Sheri Louise Dodd

Contact Details

Address:
3701 Wayzata Boulevard
Minneapolis, Minnesota
United States
Website https://www.tactilemedical.com

Stock Details

Ticker Symbol TCMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001027838
CUSIP Number 87357P100
ISIN Number US87357P1003
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Sheri Louise Dodd Chief Executive Officer & Director
Elaine M. Birkemeyer Chief Financial Officer
John David Kaercher Chief Information Officer
Daniel L. Reuvers Director & Advisor
Dr. Antonios P. Gasparis F.A.C.S., M.D. Chief Medical Officer & Member of Vascular Strategic Advisory Board
Janelle M. Strop Chief Human Resource Officer
Jerry A. Sauber Senior Vice President of Manufacturing, Operations, R&D
Kristie T. Burns Senior Vice President of Marketing & Clinical Affairs
Sherri Ferstler Senior Vice President of Sales
Sunday J. Hoy Esq. Vice President of Regulatory Affairs & Chief Compliance Officer

Latest SEC Filings

Date Type Title
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 13, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 08, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 04, 2024 10-Q Quarterly Report
Nov 04, 2024 8-K Current Report
Aug 14, 2024 4 Filing
Aug 09, 2024 4 Filing
Aug 05, 2024 10-Q Quarterly Report
Aug 05, 2024 8-K Current Report
Jul 10, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...